Medical consultation via mobile app lowers costs and delays for arthritis patients

November 5, 2017, American College of Rheumatology

Researchers in China have developed a new online consultation tool for rheumatic disease patients, which may strengthen the interaction between doctors and patients and lead to more efficient management of chronic illness, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting in San Diego.

In China, patients may choose any hospital or doctor they like for medical care, but people with often seek care in large cities where the majority of rheumatologists are located. To improve care management among these patients, researchers at multiple institutions in China collaborated to develop the Smart System of Disease Management (SSDM), a series of applications based on clinical data, and a system that includes online consultation via a mobile app.

"In China, there are over 100 million people suffering from rheumatic disease. These patients seek medical services in a hospital regularly. However, only 5,000 rheumatologists are available across the country, and most of them only practice in the top-tier hospitals in major cities," said Fei Xiao, MD, Chief Executive Officer of Cinkate Corporation and a lead author of the study. "Most arthritis patients in China must travel long distances to seek rheumatologic care at a hospital, and must stay in nearby hotels and endure long waits for a visit with the clinician," he added. "It is not uncommon for most Chinese rheumatologists to have to see up to 60 to 100 patients daily. Because of the large volume of patients who go to major hospitals for regular clinical care, physicians may only spend three minutes on average with each patient. This limits the time to do objective disease activity evaluations."

Previous research indicates that rheumatoid arthritis (RA) patients trained to use SSDM were able to perform self-management afterward, including disease activity scoring of 28 joints (DAS28) and health assessment questionnaire (HAQ) evaluations and medication and lab test data entry. The aim of this study was to evaluate the economic feasibility and medical benefits of using SSDM for online consultation with a .

From February 2015 to June 2017, 403 rheumatologists supplied 4,002 patients with RA, lupus, ankylosing spondylitis, gout, osteoarthritis, Sjögren's syndrome and other rheumatic diseases with 293 free and 3,709 paid consultations. Consulting fees ranged from RMB 10 to 500 yuan, which matched those found in hospitals in the region.

The rheumatologists implemented the education and training programs on these patients using SSDM and assisted the patients in downloading the mobile application. SSDM includes a doctor/patient interface. The patient's terminal system includes self-assessment with DAS28 and HAQ, medication management, adverse events management and laboratory records. After data entry is complete, patients may submit the data to their authorized doctor. On the basis of the data, rheumatologists may accept the request from their follow-up patients, and consult via text or voice through SSDM.

The total fees collected for consultations in the study was 477,960 yuan RMB, and 35.3 percent of patients who received online consultations lived in a different city from the rheumatologists. If these patients sought care at a hospital, in addition to registration fees and medical expenses, the average cost of transportation, accommodations, meals and lost wages was 200 to 2,800 yuan. The total cost for all the patients would have been 3,157,220 yuan RMB, which is 6.61 times higher than the cost of the online consultation and a savings of 84.86 percent for the patients.

The researchers also surveyed the patients to determine their satisfaction with SSDM, and found that 66.35 percent reported their experience with online consultation as "very satisfying."

"SSDM inspires a paradigm shift in medical care for chronic disease through empowering the patient. Through a one-time training, can input data regularly to effectively follow their progress," said Dr. Xiao. "Access to this online program also helps physicians to mine and analyze data for scientific research and publication. Based on the trajectory and real-time data, such as score, lab results, medication and patient's symptoms, physicians are able to take proactive interventions, and turn passive practice into outcome-driven care. This model can be replicated into the other disciplines and fields of chronic disease."

Explore further: New medication guidelines for rheumatic disease patients having joint replacement

Related Stories

New medication guidelines for rheumatic disease patients having joint replacement

June 17, 2017
In the first such collaboration of its kind, an expert panel of rheumatologists and orthopedic surgeons has developed guidelines for the perioperative management of anti-rheumatic medication in patients undergoing total hip ...

Age, CRP levels predict success in tapering of biologics in rheumatoid arthritis patients

November 5, 2017
Rheumatoid arthritis patients in remission may experience more successful tapering of their biologic drugs if they meet a certain set of factors, including younger age, no concomitant steroid use, and low level of serum CRP, ...

Innovative software improves chronic rheumatic disease care

December 10, 2014
(HealthDay)—For patients with chronic rheumatic disease, innovative software that aggregates, stores, and displays information can improve quality of care, according to research published online Nov. 24 in Arthritis Care ...

More coordinated care between physicians may improve lipid screenings in RA patients

November 13, 2016
Patients with rheumatoid arthritis whose rheumatologists and primary-care physicians coordinate their care have a higher likelihood of being screened for hyperlipidemia, a key risk factor for coronary heart disease, according ...

Specialist nurses as good as doctors in managing rheumatoid arthritis patients

August 28, 2013
Patients attending clinical nurse specialist clinics do not get inferior treatment to that offered by consultant rheumatologists, the results of a major new clinical trial have revealed.

Recommended for you

How environmental pollutants and genetics work together in rheumatoid arthritis

April 19, 2018
It has been known for more than three decades that individuals with a particular version of a gene—human leukocyte antigen (HLA)—have an increased risk for rheumatoid arthritis.

The bugs in your gut could make you weak in the knees

April 19, 2018
Bacteria in the gut, known as the gut microbiome, could be the culprit behind arthritis and joint pain that plagues people who are obese, according to a new study published today in JCI Insight.

Researchers identify peptide produced during cartilage deterioration as a potential source of osteoarthritis pain

April 11, 2018
Osteoarthritis is one of the most common causes of chronic pain in the world. More than 30 million people in the United States alone suffer from osteoarthritis, or OA, which can affect any moveable joint of the body, including ...

Flare-responsive hydrogel developed to treat arthritis

April 3, 2018
Arthritis flares - the unpredictable and often sudden worsening of arthritis symptoms—can be debilitating. These episodes can make the management of inflammatory arthritis, which includes rheumatoid arthritis and psoriatic ...

Drug compound shows promise against rheumatoid arthritis

March 28, 2018
Scientists have designed a new drug compound that dials down inflammation, suggesting possible future uses against autoimmune disorders such as rheumatoid arthritis.

Chromosomal loop signatures could identify poor drug response in arthritis

March 28, 2018
Chromosomal loop signatures found in blood samples obtained in early rheumatoid arthritis could identify patients that will not respond adequately to 'anchor' treatment drug methotrexate.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.